About
Small Molecule GABAa receptor Modulator
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
137
By Phase
PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05160272Collaborator
Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 Diabetes
PHASE2Completed
38 participants
Started: Jan 7, 2022 · Completed: Dec 17, 2024
NCT04429919Lead Sponsor
AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain
PHASE2Completed
99 participants
Started: Jun 22, 2020 · Completed: Oct 4, 2024
Locations (1)
Headquarters
Erkrath, Germany
Map
Loading map...